\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ none\\ \\-\\ incidental\\ finding\\,\\ if\\ less\\ than\\ 4\\ cm\\ unlikely\\ to\\ hemorrhage\\.\\ large\\ or\\ symptomatic\\ lesions\\ are\\ resected\\ or\\ embolized\\.\ \(0\)\
\-\ axial\\ ct\\ image\\ through\\ the\\ kidneys\\ without\\ and\\ with\\ iv\\ contrast\\ demonstrates\\ a\\ large\\ heterogeneous\\ exophytic\\ mass\\ in\\ the\\ mid\\ pole\\ of\\ the\\ left\\ kidney\\ with\\ focal\\ regions\\ of\\ hypodensity\\ corresponding\\ to\\ macroscopic\\ fat\\.\\ \\ the\\ lesion\\ enhances\\ heterogeneously\\ and\\ displaces\\ the\\ renal\\ parenchyma\\.\\ \\ there\\ is\\ stranding\\ of\\ the\\ perirenal\\ fat\\.\ \(0\)\
\-\ angiomyolipoma\ \(35\)\
\-\ angiomyolipoma\ \(35\)\
\-\ renal\\ cell\\ cancer\ \(1\)\
\-\ 54\\ female\\ with\\ questionable\\ renal\\ lesion\\ on\\ outside\\ ultrasound\\.\ \(0\)\
\-\ angiomyolipoma\\ \\(aml\\)\\ is\\ a\\ benign\\,\\ well\\ marginated\\,\\ nonencapsulated\\ hamartomatous\\ renal\\ neoplasm\\ composed\\ of\\ fat\\,\\ vascular\\,\\ and\\ smooth\\ muscle\\ elements\\.\\ most\\ extend\\ beyond\\ the\\ renal\\ capsule\\.\\ usually\\ solitary\\,\\ isolated\\ aml\\ is\\ more\\ common\\ in\\ women\\ of\\ childbearing\\ age\\.\ \(0\)\
\-\ fat\\ is\\ hypodense\\ on\\ ct\\ \\(hu\\ \\<\\ \\-\\ 50\\)\\,\\ hyperechoic\\ on\\ ultrasound\\,\\ and\\ hyperintense\\ on\\ mr\\ t1\\,\\ confirmed\\ with\\ fat\\ suppression\\.\\ demonstration\\ of\\ fatty\\ attenuation\\ in\\ a\\ renal\\ tumor\\ on\\ ct\\ is\\ virtually\\ diagnostic\\ of\\ an\\ aml\\.\\ \\ case\\ reports\\ exist\\ of\\ renal\\ cell\\ carcinomas\\ or\\ oncocytomas\\ with\\ engulfed\\ fat\\ that\\ appear\\ to\\ have\\ foci\\ of\\ fat\\ density\\ on\\ ct\\.\\ \\ nonfatty\\ amls\\ are\\ rare\\.\\ \\ if\\ calcification\\ present\\ consider\\ rcc\\.\\ \ \(0\)\
\-\ associations\\:\\ \\ \ \(0\)\
\-\ lymphangioleiomyomatosis\ \(13\)\
\-\ 40\\%\\ with\\ aml\\ have\\ tuberous\\ sclerosis\ \(0\)\
\-\ 80\\%\\ with\\ tuberous\\ sclerosis\\ have\\ aml\\,\\ multiple\\ and\\ bilateral\ \(0\)\
\-\ complications\\:\\ spontaneously\\ hemorrhage\\ or\\ hemorrhage\\ with\\ trauma\\,\\ may\\ be\\ massive\\.\\ \\ absence\\ of\\ elastic\\ tissue\\ in\\ the\\ tumor\\ vessels\\ predisposes\\ the\\ patient\\ to\\ aneurysm\\ formation\\ and\\ spontaneous\\ hemorrhage\\,\\ if\\ less\\ than\\ 4\\ cm\\ unlikely\\ to\\ hemorrhage\\.\\ large\\ or\\ symptomatic\\ lesions\\ are\\ resected\\ or\\ embolized\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ aml\\:\\ 0\\.3828214582047233\ \(0\)\
\-\ renal\\:\\ 0\\.2770739853336181\ \(0\)\
\-\ fat\\:\\ 0\\.2767774102005786\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.2127825459107334\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.20398212947238967\ \(0\)\
\-\ embolized\\:\\ 0\\.1470126275421198\ \(0\)\
\-\ or\\:\\ 0\\.1326730119538284\ \(0\)\
\-\ tuberous\\:\\ 0\\.1267716531929782\ \(0\)\
\-\ of\\:\\ 0\\.12438847439783615\ \(0\)\
\-\ resected\\:\\ 0\\.11634237434004584\ \(0\)\
\-\ on\\:\\ 0\\.11518131034240855\ \(0\)\
\-\ the\\:\\ 0\\.11414671575498889\ \(0\)\
\-\ unlikely\\:\\ 0\\.11261949454475063\ \(0\)\
\-\ if\\:\\ 0\\.11079370881895735\ \(0\)\
\-\ nonencapsulated\\:\\ 0\\.10164984631997355\ \(0\)\
\-\ engulfed\\:\\ 0\\.10164984631997355\ \(0\)\
\-\ with\\:\\ 0\\.09957023718531897\ \(0\)\
\-\ symptomatic\\:\\ 0\\.09775125576341864\ \(0\)\
\-\ ct\\:\\ 0\\.09679495380549089\ \(0\)\
\-\ large\\:\\ 0\\.09554350018024967\ \(0\)\
\-\ have\\:\\ 0\\.09525846394253885\ \(0\)\
\-\ nonfatty\\:\\ 0\\.09392628888982876\ \(0\)\
\-\ oncocytomas\\:\\ 0\\.09143985876058912\ \(0\)\
\-\ sclerosis\\:\\ 0\\.0905479879907721\ \(0\)\
\-\ amls\\:\\ 0\\.08940829742102781\ \(0\)\
\-\ predisposes\\:\\ 0\\.0876906367828068\ \(0\)\
\-\ is\\:\\ 0\\.08703474521781976\ \(0\)\
\-\ less\\:\\ 0\\.08648486531164948\ \(0\)\
\-\ childbearing\\:\\ 0\\.08620273145968398\ \(0\)\
\-\ hamartomatous\\:\\ 0\\.08489030595222684\ \(0\)\
\-\ elastic\\:\\ 0\\.08371630133044433\ \(0\)\
\-\ associations\\:\\ 0\\.08265428496791444\ \(0\)\
\-\ perirenal\\:\\ 0\\.081684739990883\ \(0\)\
\-\ to\\:\\ 0\\.07945216557777716\ \(0\)\
\-\ lymphangioleiomyomatosis\\:\\ 0\\.07919830986164336\ \(0\)\
\-\ and\\:\\ 0\\.07880614217510751\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0784127288501005\ \(0\)\
\-\ exist\\:\\ 0\\.07544908788386104\ \(0\)\
\-\ suppression\\:\\ 0\\.07493072753776964\ \(0\)\
\-\ rcc\\:\\ 0\\.07493072753776964\ \(0\)\
\-\ cm\\:\\ 0\\.07300902160380189\ \(0\)\
\-\ lesions\\:\\ 0\\.07300902160380189\ \(0\)\
\-\ cell\\:\\ 0\\.07272105021127208\ \(0\)\
\-\ are\\:\\ 0\\.07235692862007087\ \(0\)\
\-\ macroscopic\\:\\ 0\\.0722435219225172\ \(0\)\
\-\ demonstration\\:\\ 0\\.0722435219225172\ \(0\)\
\-\ than\\:\\ 0\\.07206324420325236\ \(0\)\
\-\ virtually\\:\\ 0\\.07110938402663389\ \(0\)\
\-\ carcinomas\\:\\ 0\\.07110938402663389\ \(0\)\
\-\ hu\\:\\ 0\\.07075561659939439\ \(0\)\
\-\ displaces\\:\\ 0\\.07008009232199376\ \(0\)\
\-\ hypodensity\\:\\ 0\\.06913789150102209\ \(0\)\
\-\ composed\\:\\ 0\\.06913789150102209\ \(0\)\
\-\ exophytic\\:\\ 0\\.06826918647015474\ \(0\)\
\-\ marginated\\:\\ 0\\.0669567609626976\ \(0\)\
\-\ tumor\\:\\ 0\\.06649347024766766\ \(0\)\
\-\ beyond\\:\\ 0\\.06623762513059343\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.06600786981549524\ \(0\)\
\-\ massive\\:\\ 0\\.06534573020997723\ \(0\)\
\-\ questionable\\:\\ 0\\.0647207399783852\ \(0\)\
\-\ spontaneously\\:\\ 0\\.0647207399783852\ \(0\)\
\-\ in\\:\\ 0\\.06324888174668354\ \(0\)\
\-\ elements\\:\\ 0\\.0630320591692496\ \(0\)\
\-\ consider\\:\\ 0\\.06252161551123722\ \(0\)\
\-\ capsule\\:\\ 0\\.06219386429474815\ \(0\)\
\-\ hypodense\\:\\ 0\\.06171963366179247\ \(0\)\
\-\ lesion\\:\\ 0\\.06094629589408697\ \(0\)\
\-\ isolated\\:\\ 0\\.06040720815433533\ \(0\)\
\-\ fatty\\:\\ 0\\.06040720815433533\ \(0\)\
\-\ 54\\:\\ 0\\.05987010476260933\ \(0\)\
\-\ corresponding\\:\\ 0\\.059483612677480056\ \(0\)\
\-\ extend\\:\\ 0\\.058630746651415426\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.058514067700448646\ \(0\)\
\-\ solitary\\:\\ 0\\.05817118717002292\ \(0\)\
\-\ women\\:\\ 0\\.05720164219299151\ \(0\)\
\-\ stranding\\:\\ 0\\.05689634260207633\ \(0\)\
\-\ enhances\\:\\ 0\\.056027637571208995\ \(0\)\
\-\ pole\\:\\ 0\\.05539589621066006\ \(0\)\
\-\ spontaneous\\:\\ 0\\.05530850173910482\ \(0\)\
\-\ kidneys\\:\\ 0\\.054715212063751864\ \(0\)\
\-\ regions\\:\\ 0\\.054551345316362465\ \(0\)\
\-\ smooth\\:\\ 0\\.052479191079439456\ \(0\)\
\-\ foci\\:\\ 0\\.051951625662190526\ \(0\)\
\-\ parenchyma\\:\\ 0\\.05163414726359601\ \(0\)\
\-\ outside\\:\\ 0\\.051025102893054536\ \(0\)\
\-\ absence\\:\\ 0\\.05067504044939115\ \(0\)\
\-\ hyperintense\\:\\ 0\\.05056075495520565\ \(0\)\
\-\ formation\\:\\ 0\\.0503914949208918\ \(0\)\
\-\ appear\\:\\ 0\\.050060498167934\ \(0\)\
\-\ 80\\:\\ 0\\.049581738887079174\ \(0\)\
\-\ reports\\:\\ 0\\.04942661705932233\ \(0\)\
\-\ vessels\\:\\ 0\\.04932438938814214\ \(0\)\
\-\ complications\\:\\ 0\\.04868183624926423\ \(0\)\
\-\ attenuation\\:\\ 0\\.04863391042053206\ \(0\)\
\-\ diagnostic\\:\\ 0\\.048444242215585645\ \(0\)\
\-\ aneurysm\\:\\ 0\\.048397325354682205\ \(0\)\
\-\ rare\\:\\ 0\\.04798373296109313\ \(0\)\
\-\ incidental\\:\\ 0\\.047116155794795056\ \(0\)\
\-\ confirmed\\:\\ 0\\.04686852920400951\ \(0\)\
\-\ 40\\:\\ 0\\.046746749434458564\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.046004927327800864\ \(0\)\
\-\ mid\\:\\ 0\\.04574361161316408\ \(0\)\
\-\ iv\\:\\ 0\\.04541639514115034\ \(0\)\
\-\ calcification\\:\\ 0\\.0453806238808867\ \(0\)\
\-\ muscle\\:\\ 0\\.045133389757494695\ \(0\)\
\-\ kidney\\:\\ 0\\.04465479370313058\ \(0\)\
\-\ 50\\:\\ 0\\.04439026524442997\ \(0\)\
\-\ benign\\:\\ 0\\.04366296324266568\ \(0\)\
\-\ neoplasm\\:\\ 0\\.04339080685882263\ \(0\)\
\-\ cancer\\:\\ 0\\.042336940737789215\ \(0\)\
\-\ density\\:\\ 0\\.04214830463417602\ \(0\)\
\-\ vascular\\:\\ 0\\.04196280887356405\ \(0\)\
\-\ finding\\:\\ 0\\.04178035060730124\ \(0\)\
\-\ mr\\:\\ 0\\.04112766137717608\ \(0\)\
\-\ image\\:\\ 0\\.040650383366106914\ \(0\)\
\-\ usually\\:\\ 0\\.040014779991506134\ \(0\)\
\-\ age\\:\\ 0\\.03990499843351878\ \(0\)\
\-\ t1\\:\\ 0\\.03960324240695292\ \(0\)\
\-\ focal\\:\\ 0\\.03802005418301929\ \(0\)\
\-\ through\\:\\ 0\\.037837082288453734\ \(0\)\
\-\ trauma\\:\\ 0\\.036914517983274164\ \(0\)\
\-\ axial\\:\\ 0\\.03671583091222438\ \(0\)\
\-\ common\\:\\ 0\\.03604706595441379\ \(0\)\
\-\ more\\:\\ 0\\.034902463755364314\ \(0\)\
\-\ none\\:\\ 0\\.03473635775265512\ \(0\)\
\-\ bilateral\\:\\ 0\\.034160688922891036\ \(0\)\
\-\ without\\:\\ 0\\.03352668755960496\ \(0\)\
\-\ tissue\\:\\ 0\\.033343314172676206\ \(0\)\
\-\ most\\:\\ 0\\.033079710227765326\ \(0\)\
\-\ present\\:\\ 0\\.032615845622006506\ \(0\)\
\-\ may\\:\\ 0\\.03198651933309998\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03193297411712389\ \(0\)\
\-\ case\\:\\ 0\\.03193297411712389\ \(0\)\
\-\ multiple\\:\\ 0\\.031089670983639163\ \(0\)\
\-\ contrast\\:\\ 0\\.03088359069485896\ \(0\)\
\-\ well\\:\\ 0\\.03077714601388928\ \(0\)\
\-\ female\\:\\ 0\\.030671708566508728\ \(0\)\
\-\ that\\:\\ 0\\.027583624954812775\ \(0\)\
\-\ be\\:\\ 0\\.025784656395464893\ \(0\)\
\-\ there\\:\\ 0\\.025291214802951628\ \(0\)\
\-\ an\\:\\ 0\\.024305984110850613\ \(0\)\
\-\ mass\\:\\ 0\\.024279075771276793\ \(0\)\
\-\ left\\:\\ 0\\.021682463588003794\ \(0\)\
\-\ patient\\:\\ 0\\.020673603135474526\ \(0\)\
